Dr Romina Vuono

Name:	Dr Romina Vuono
Affiliation:	John Van Geest Centre For Brain Repair, University of Cambridge, Clinical
E-mail:	(only provided to users who are logged into talks.cam)
Last login:	Thu Jul 18 15:05:43 +0000 2019

Public lists managed by Dr Romina Vuono

• Clinical Neurosciences Seminars
• Romina Vuono

Talks given by Dr Romina Vuono

Obviously this only lists talks that are listed through talks.cam. Furthermore, this facility only works if the speaker's e-mail was specified in a talk. Most talks have not done this.

• "Polymerase Chain Reaction: Methods, Principles and Application"

Talks organised by Dr Romina Vuono

This list is based on what was entered into the 'organiser' field in a talk. It may not mean that Dr Romina Vuono actually organised the talk, they may have been responsible only for entering the talk into the talks.cam system.

• Starting a research project at the Clinical School - Ethics and other considerations
• Crossing over OMICS in mitochondrial diseases affecting the optic nerve
• The Ultrastructure of Retinal Circuitry in Health and Disease
• Microglia-mediated synapse loss in neurodegeneration: novel roles for TDP-43
• To initiate and share opportunities for people to participate in activities linked to research on Parkinson’s disease
• Direct neuronal reprogramming of patient skin fibroblasts: a new approach to study idiopathic Parkinson's disease
• Calcium-mediated processes as a potential common denominator in motor neuron degeneration
• The new framework in European Family Law
• Neurons without batteries: Dissecting cell type-specific neuronal contribution to mitochondrial disease
• Long-term stability of human neurons in an organotypic slice culture system – a new model to study disease mechanisms of neurological disorders
• Influencing axon regeneration after spinal cord injury
• Exploring disease mechanisms in a novel group of neurological diseases caused by mutations in the RNA exosome
• Gene therapy for glaucoma
• Using Drosophila models to decipher rare and common neurological disorders
• The coding and non-coding transcriptome of the human fetal striatum from a single-cell perspective
• Whole-Tissue 3D Imaging to Decipher the Neuro-Immune Interplay in Physiology and Disease
• Graded levels of Schwann cell c-Jun in vivo determines effects on development, remyelination and tumorigenesis
• Investigating mechanisms of synaptic dysfunction in an organotypic slice culture model of Alzheimer's disease
• Chronic traumatic encephalopathy. A vascular problem?
• Engineered neural networks as self-organised computational substrates in the healthy and lesioned CNS
• Redefining microglia states in health and disease
• Boosting functional recovery in the optic nerve
• Neuronal Intrinsic and Extrinsic Factors Modulating Axon Growth After Spinal Cord Injury in Young and Aged Mice
• Neuron-glia signalling mechanisms regulating brain development, homeostasis and pathological cascades
• How do mitochondrial DNA mutations arise and cause neurological disease?
• "Mitochondrial Dynamics and Diversity in the Nervous System"
• TBC
• "EEG correlates of entorhinal cortex dysfunction in MCI" & "TBC"
• Neuron-glia signalling mechanisms regulating brain development, homeostasis and pathological cascades
• Development and activity-dependent plasticity of olfactory bulb dopaminergic neurons
• Complement and microglia mediated sensory-motor synaptic loss in Spinal Muscular Atrophy
• Modelling mitochondrial dysfunction in Parkinson’s disease: mitophagy, calcium and beyond
• Deficits in axonal transport in ALS and Charcot-Marie-Tooth disease models
• Imaging and characterising the protein aggregates associated with neurodegenerative diseases
• On the morphology and vulnerability of dopamine neurons in Parkinson's disease
• Aspects of the earliest AD pathology and the NGF metabolic deregulation
• ”Huntington´s disease and autophagy - insights from human and mouse model systems”
• Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation
• Anti-scarring therapies for ocular fibrosis
• Keeping axons alive: from mice, flies and fish to people
• "Epigenetic studies in Alzheimer's disease"
• Building cortical networks: from molecules to function
• Role of microRNAs in axonal development and neuronal connectivity
• Heterogeneity in hearing loss and its impact on development of treatments
• Induction of a transmissible tau pathology by traumatic brain injury
• Down syndrome cathepsin deficits and Alzheimer’s disease
• Modulation of Astroglial Lipocalin 2 Expression with RNA Nanotherapeutics
• Central nervous system pericytes: new insight on their identity and potential role in brain repair
• Modelling synucleinopathy in mouse
• Systemic α-synuclein injection triggers the selective pathology of Parkinson’s disease
• Twenty years of alpha-synuclein in Parkinson’s disease and Dementia with Lewy bodies